Prevalence Of Pulmonary Tuberculosis Before And After The Covid-19 Pandemic In Nueva Ecija&#039;S Third District

Edralyn  Costales,

Prevalence Of Pulmonary Tuberculosis Before And After The Covid-19 Pandemic In Nueva Ecija'S Third District

Abstract:

This study determined the prevalence of Pulmonary Tuberculosis (PTB) before and after the COVID-19 pandemic in the 3rd District of Nueva Ecija. Specifically, it identified the profile of PTB patients in terms of age and sex. It also determined the prevalence rate of PTB before the COVID19 pandemic (2017–2019) and after the COVID-19 pandemic (2022–2024). Finally, it is determined if there is a significant difference in the prevalence rate of PTB before and after the COVID-19 pandemic. The researcher utilized a retrospective research design. The data were collected from three selected hospitals in the 3rd District of Nueva Ecija. The profile of PTB patients was analyzed using frequency and percentage, while the prevalence rate was determined using the formula for prevalence. To determine the significant difference in the prevalence rate of PTB before and after the COVID-19 pandemic, the Independent Samples T-test and Mann-Whitney U test were used. The findings of the study showed that most PTB patients before the pandemic were in the age group of 51–75 years old, while after the pandemic, most were in the age group of 26–50 years old. In terms of sex, most PTB patients both before and after the pandemic were male. The prevalence rate of PTB before the pandemic was 1.50, while after the pandemic, it was 0.966. The statistical analysis showed that there is no significant difference in the prevalence rate of PTB before and after the COVID-19 pandemic (p = 0.510). Based on the findings, the researcher recommended that the Department of Health and local government units should continue to strengthen their TB control programs and prioritize the screening and treatment of PTB patients, especially during pandemics.

References:

Amere, Nayak, G. A., Salindri, P., Narayan, A. D., Magee, K. M. & J., M. (2018). Contribution of Smoking to Tuberculosis Incidence and Mortality in High-Tuberculosis-Burden Countries. American Journal of Epidemiology, 187. https://pubmed.ncbi.nlm.nih.gov/29635332/
Atibagos-Nacion, N., & Gonzaga, A. C. (2024). An application of spatial analysis and GIS in tuberculosis (TB) cases in Central Luzon, Philippines. E3S Web of Conferences, 501, 02005. https://doi.org/10.1051/e3sconf/202450102005
Burki, T. (2022). Tuberculosis control: Getting back on track in the era of COVID-19. The Lancet Respiratory Medicine, 10(12), e112. https://doi.org/10.1016/S2213-2600(22)00442-8
Calnan, M., Moran, A., & Jassim AlMossawi, H. (2022). Maintaining essential tuberculosis services during the COVID-19 pandemic, Philippines. Bulletin of the World Health Organization, 100(2), 127–134. https://doi.org/10.2471/BLT.21.286807
Crowder, R., Geocaniga-Gaviola, D. M., Fabella, R. A., et al. (2021). Impact of shelter-in-place orders on TB case notifications and mortality in the Philippines during the COVID-19 pandemic. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 25, 100282. https://doi.org/10.1016/j.jctube.2021.100282
Dychiao, R. G. K., Capistrano, M. P. R., Flores, G. P., & Yap, C. D. D. (2022). Barriers to tuberculosis care in the Philippines. The Lancet Respiratory Medicine, 10(6), e55. https://doi.org/10.1016/S2213-2600(22)00181-3
Endale Mangamba, L.-M., et al. (2023). Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: A cross-sectional study. Pan African Medical Journal, 44(204). https://doi.org/10.11604/pamj.2023.44.204.38541
World Health Organization (WHO). (2023). Global Tuberculosis Report 2023. https://www.who.int/teams/global-tuberculosis-programme/tb-reports